Zydus Lifesciences Limited
ZYDUSLIFE
Ранг среди акций
#1750
Zydus Lifesciences Limited, an Indian enterprise founded in Ahmedabad in 1952,... Zydus Lifesciences Limited, an Indian enterprise founded in Ahmedabad in 1952, operates globally in the pharmaceutical and consumer goods sectors. Renamed from Cadila Healthcare Limited in February 2022, the company manages the entire lifecycle of pharmaceutical products, from research and development to manufacturing, marketing, and distribution. Its extensive reach covers India, the United States, Europe, Latin America, the Asia Pacific region, and Africa. The company's pharmaceutical division provides a broad spectrum of offerings, including finished dosage human formulations (such as generics, branded generics, and specialized treatments like biosimilars and vaccines), as well as active pharmaceutical ingredients (APIs). Zydus focuses on therapeutic areas like pain management, neurology, dermatology, and liver diseases, among others. Additionally, it is developing a pipeline of biological products aimed at conditions such as oncology, autoimmune disorders, nephrology, ophthalmology, inflammation, rheumatology, hepatology, and infectious diseases. In its consumer products segment, Zydus offers popular wellness brands including Complan, the EverYuth range of skincare products, Nycil, Glucon-D glucose powder, Nutralite, and the Nutralite Doodhshakti dairy product line. Beyond these core operations, the company is also involved in investment activities, animal health and veterinary services, pharmacy retail, and human resource supply and administration.
Цена акции
$12.04
Рыночная капитализация
$12.01B
Изменение (1 день)
-2.15%
Изменение (1 год)
6.00%
Страна
IN
Торговля Zydus Lifesciences Limited (ZYDUSLIFE)
Категория
Healthcare
Выручка компании Zydus Lifesciences Limited (ZYDUSLIFE)
Выручка на Jun 2026 TTM: $3.16B
Согласно последним финансовым отчетам Zydus Lifesciences Limited, текущая выручка компании (TTM) составляет $3.16B. В 2025 году компания получила выручку $2.72B больше, чем выручке в 2024 году, которая составила $2.34B. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Zydus Lifesciences Limited с 2004 по 2026
Выручка на конец каждого года
| Год | Выручка | Изменить |
|---|---|---|
| 2026 (TTM) | $3.16B | 16.11% |
| 2025 | $2.72B | 15.92% |
| 2024 | $2.34B | 11.77% |
| 2023 | $2.10B | 5.37% |
| 2022 | $1.99B | 1.17% |
| 2021 | $1.97B | 4.00% |
| 2020 | $1.89B | -0.21% |
| 2019 | $1.90B | 3.69% |
| 2018 | $1.83B | 26.46% |
| 2017 | $1.45B | 1.62% |
| 2016 | $1.42B | 2.63% |
| 2015 | $1.39B | 15.37% |
| 2014 | $1.20B | 3.47% |
| 2013 | $1.16B | 15.71% |
| 2012 | $1.00B | 0.20% |
| 2011 | $1.00B | 22.04% |
| 2010 | $820.89M | 45.59% |
| 2009 | $563.82M | -0.43% |
| 2008 | $566.27M | 37.48% |
| 2007 | $411.90M | 26.93% |
| 2006 | $324.50M | 14.00% |
| 2005 | $284.66M | 3.30% |
| 2004 | $275.56M | 0.00% |
Выручка аналогичных компаний или конкурентов
| Компания | Выручка | Разница в выручке | Страна |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 109.54% |
IN
|
